Montreal, Canada

Jean-Chrisophe Leroux


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Chrisophe Leroux

Introduction

Jean-Chrisophe Leroux is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable compositions. His work focuses on enhancing the delivery of active principles through innovative formulations.

Latest Patents

Leroux holds a patent for a pharmaceutical composition with gelling properties containing a tyrosine derivative. This invention relates to an injectable pharmaceutical composition that includes an active principle, a hydrophobic and bio-compatible organic liquid, and an organogelling substance. The organogelling substance is specifically chosen from L-tyrosine derivatives, which have the capacity to bind together via low-energy bonds. This composition is designed to serve as a vector for the release of active principles, showcasing Leroux's commitment to advancing pharmaceutical technology. He has 1 patent to his name.

Career Highlights

Throughout his career, Leroux has worked with prominent organizations, including Ethypharm, Inc. and Université de Montreal. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Guillaume Bastiat. Their partnership has likely fostered innovative ideas and advancements in pharmaceutical compositions.

Conclusion

Jean-Chrisophe Leroux's contributions to the field of pharmaceuticals through his innovative patent demonstrate his expertise and dedication to improving drug delivery systems. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…